The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
Clinical trial NCT06746194 · RECRUITING
Trial details
- NCT number
- NCT06746194
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-03
- Primary completion
- 2028-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.